May 20, 2021
A batch of new medicines hit the Japan market on May 19 upon their NHI price listing, including Janssen Pharmaceutical’s multiple myeloma (MM) drug Darzquro (daratumumab + vorhyaluronidase alfa), according to press releases by the manufacturers. Darzquro is a subcutaneous...read more